These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19047910)

  • 1. The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study.
    Verbruggen MB; van Diest PJ; Baak JP; Broeckaert MA; Kenemans P; Verheijen RH
    Int J Gynecol Pathol; 2009 Jan; 28(1):35-40. PubMed ID: 19047910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
    Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].
    Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
    Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
    Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
    Tropé CG; Abeler V; Baekelandt M; Kaern J
    Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
    Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
    Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE
    Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
    Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of restaging borderline ovarian tumors: single institution experience and review of the literature.
    Zapardiel I; Rosenberg P; Peiretti M; Zanagnolo V; Sanguineti F; Aletti G; Landoni F; Bocciolone L; Colombo N; Maggioni A
    Gynecol Oncol; 2010 Nov; 119(2):274-7. PubMed ID: 20797775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment.
    Brugghe J; Baak JP; Wiltshaw E; Brinkhuis M; Meijer GA; Fisher C
    Gynecol Oncol; 1998 Jan; 68(1):47-53. PubMed ID: 9454660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
    Provenza C; Young RH; Prat J
    Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors in ovarian carcinoma].
    Sliutz G
    Wien Med Wochenschr; 1996; 146(1-2):14-7. PubMed ID: 8835490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors.
    Lazarou A; Fotopoulou C; Coumbos A; Sehouli J; Vasiljeva J; Braicu I; Burger H; Kuehn W
    Anticancer Res; 2014 Nov; 34(11):6725-30. PubMed ID: 25368281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.